ReutersNovartis gene therapy approval signals new cancer treatment eraReuters(Reuters) – Novartis AG on Wednesday won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment… Continue reading
New AtlasVideo gamers tasked with helping develop new molecule for controlling CRISPRNew AtlasEarlier in 2016 Eterna players were tasked with designing a novel molecule to assist with the creation of a simple and accurate blood test for tuberculosis. … Continue reading
Conventional and novel stem cell based therapies for androgenic alopeciaDove Medical PressBiologic factors that include signaling from stem cells, dermal papilla cells, and platelet-rich plasma are some of the current therapeutic agents being studied f… Continue reading
Market News Call |
Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool Novartis’ Kymriah and Kite Pharma’s (soon to be Gilead Sciences’) CAR-Ts work similarly. Each involves removing a patient’s T–cells and shipping them to a facility where they’re engineered to spot and bind to CD19, a protein commonly expressed by B … Gilead Sciences’ Purchase Deal With Kite Pharma: Potential Scenarios And Associated ActionsSeeking Alpha |
Market News Call |
Novartis $475000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool Novartis’ Kymriah and Kite Pharma’s (soon to be Gilead Sciences’) CAR-Ts work similarly. Each involves removing a patient’s T–cells and shipping them to a facility where they’re engineered to spot and bind to CD19, a protein commonly expressed by B … Gilead Sciences’ Purchase Deal With Kite Pharma: Potential Scenarios And Associated ActionsSeeking Alpha |
|
Ground-Breaking Immunotherapy for Childhood Leukemia Gets FDA OK
Health Essentials from Cleveland Clinic (blog) It is a type of immunotherapy, a one-time infusion that uses the body’s own defenses to attack the cancer. It’s approved for use in certain children and young adults up to age 25, who are fighting a form of acute lymphoblastic leukemia (ALL). ALL is a … |
Business Insider |
A startup raised $127 million to treat genetic diseases without using CRISPR
Business Insider The gene-editing system CRISPR is the hottest subject in biology because of the technique’s ability to change DNA letters and potentially cure genetic disease. So what could be better? What about a way to edit genes with no CRISPR at all. A startup … |
KING5.com |
US clears breakthrough gene therapy for childhood leukemia
KING5.com The Food and Drug Administration said the approval on Wednesday was historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers … First Gene Therapy Treatment Approved in USSmithsonian FDA approves a ‘historic’ new type of leukemia treatmentToday.com Leukemia-fighting gene therapy has ups (it usually works) and downs ($475K price, brutal side effects)The Mercury News FDA.gov –National Cancer Institute –Novartis all 492 news articles » |